Report Detail
Global Opioid Tolerance Treatment Market Insights, Forecast to 2025
- RnM3498250 |
- 06 June, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence, analgesia or desired therapeutic response is not received.
The global Opioid Tolerance Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioid Tolerance Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Opioid Tolerance Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid Tolerance Treatment in these regions.
This research report categorizes the global Opioid Tolerance Treatment market by top players/brands, region, type and end user. This report also studies the global Opioid Tolerance Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim International
GlaxoSmithKline
Teva Pharmaceutical Industries
Mylan
Otsuka Pharmaceutical
Johnson & Johnson Services
Aurobindo Pharma
Pfizer
Acorda Therapeutics
Zydus Cadila
Opioid Tolerance Treatment market size by Type
NMDA Antagonists
Alpha2-Adrenoceptor Agonists
Opioid Tolerance Treatment market size by Applications
Hospitals and Ambulatory Surgery Centers
Rehabilitation Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Opioid Tolerance Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Opioid Tolerance Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioid Tolerance Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Opioid Tolerance Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Opioid Tolerance Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid Tolerance Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Opioid Tolerance Treatment Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Opioid Tolerance Treatment Market Size Growth Rate by Type
- 1.4.2 NMDA Antagonists
- 1.4.3 Alpha2-Adrenoceptor Agonists
- 1.5 Market by Application
- 1.5.1 Global Opioid Tolerance Treatment Market Size Growth Rate by Application
- 1.5.2 Hospitals and Ambulatory Surgery Centers
- 1.5.3 Rehabilitation Centers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioid Tolerance Treatment Market Size
- 2.1.1 Global Opioid Tolerance Treatment Revenue 2014-2025
- 2.1.2 Global Opioid Tolerance Treatment Sales 2014-2025
- 2.2 Opioid Tolerance Treatment Growth Rate by Regions
- 2.2.1 Global Opioid Tolerance Treatment Sales by Regions
- 2.2.2 Global Opioid Tolerance Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Opioid Tolerance Treatment Sales by Manufacturers
- 3.1.1 Opioid Tolerance Treatment Sales by Manufacturers
- 3.1.2 Opioid Tolerance Treatment Sales Market Share by Manufacturers
- 3.2 Opioid Tolerance Treatment Revenue by Manufacturers
- 3.2.1 Opioid Tolerance Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Opioid Tolerance Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Opioid Tolerance Treatment Price by Manufacturers
- 3.4 Opioid Tolerance Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Opioid Tolerance Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioid Tolerance Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioid Tolerance Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Opioid Tolerance Treatment Sales by Type
- 4.2 Global Opioid Tolerance Treatment Revenue by Type
- 4.3 Opioid Tolerance Treatment Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Opioid Tolerance Treatment Breakdown Data by Application
6 North America
- 6.1 North America Opioid Tolerance Treatment by Country
- 6.1.1 North America Opioid Tolerance Treatment Sales by Country
- 6.1.2 North America Opioid Tolerance Treatment Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Opioid Tolerance Treatment by Type
- 6.3 North America Opioid Tolerance Treatment by Application
7 Europe
- 7.1 Europe Opioid Tolerance Treatment by Country
- 7.1.1 Europe Opioid Tolerance Treatment Sales by Country
- 7.1.2 Europe Opioid Tolerance Treatment Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioid Tolerance Treatment by Type
- 7.3 Europe Opioid Tolerance Treatment by Application
8 Asia Pacific
- 8.1 Asia Pacific Opioid Tolerance Treatment by Country
- 8.1.1 Asia Pacific Opioid Tolerance Treatment Sales by Country
- 8.1.2 Asia Pacific Opioid Tolerance Treatment Revenue by Country
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Opioid Tolerance Treatment by Type
- 8.3 Asia Pacific Opioid Tolerance Treatment by Application
9 Central & South America
- 9.1 Central & South America Opioid Tolerance Treatment by Country
- 9.1.1 Central & South America Opioid Tolerance Treatment Sales by Country
- 9.1.2 Central & South America Opioid Tolerance Treatment Revenue by Country
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 Central & South America Opioid Tolerance Treatment by Type
- 9.3 Central & South America Opioid Tolerance Treatment by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Opioid Tolerance Treatment by Country
- 10.1.1 Middle East and Africa Opioid Tolerance Treatment Sales by Country
- 10.1.2 Middle East and Africa Opioid Tolerance Treatment Revenue by Country
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Opioid Tolerance Treatment by Type
- 10.3 Middle East and Africa Opioid Tolerance Treatment by Application
11 Company Profiles
- 11.1 Boehringer Ingelheim International
- 11.1.1 Boehringer Ingelheim International Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Boehringer Ingelheim International Opioid Tolerance Treatment Products Offered
- 11.1.5 Boehringer Ingelheim International Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GlaxoSmithKline Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GlaxoSmithKline Opioid Tolerance Treatment Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Teva Pharmaceutical Industries
- 11.3.1 Teva Pharmaceutical Industries Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pharmaceutical Industries Opioid Tolerance Treatment Products Offered
- 11.3.5 Teva Pharmaceutical Industries Recent Development
- 11.4 Mylan
- 11.4.1 Mylan Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mylan Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mylan Opioid Tolerance Treatment Products Offered
- 11.4.5 Mylan Recent Development
- 11.5 Otsuka Pharmaceutical
- 11.5.1 Otsuka Pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Otsuka Pharmaceutical Opioid Tolerance Treatment Products Offered
- 11.5.5 Otsuka Pharmaceutical Recent Development
- 11.6 Johnson & Johnson Services
- 11.6.1 Johnson & Johnson Services Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson Services Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson Services Opioid Tolerance Treatment Products Offered
- 11.6.5 Johnson & Johnson Services Recent Development
- 11.7 Aurobindo Pharma
- 11.7.1 Aurobindo Pharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Aurobindo Pharma Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Aurobindo Pharma Opioid Tolerance Treatment Products Offered
- 11.7.5 Aurobindo Pharma Recent Development
- 11.8 Pfizer
- 11.8.1 Pfizer Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Opioid Tolerance Treatment Products Offered
- 11.8.5 Pfizer Recent Development
- 11.9 Acorda Therapeutics
- 11.9.1 Acorda Therapeutics Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Acorda Therapeutics Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Acorda Therapeutics Opioid Tolerance Treatment Products Offered
- 11.9.5 Acorda Therapeutics Recent Development
- 11.10 Zydus Cadila
- 11.10.1 Zydus Cadila Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Zydus Cadila Opioid Tolerance Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Zydus Cadila Opioid Tolerance Treatment Products Offered
- 11.10.5 Zydus Cadila Recent Development
12 Future Forecast
- 12.1 Opioid Tolerance Treatment Market Forecast by Regions
- 12.1.1 Global Opioid Tolerance Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Opioid Tolerance Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Opioid Tolerance Treatment Market Forecast by Type
- 12.2.1 Global Opioid Tolerance Treatment Sales Forecast by Type 2019-2025
- 12.2.2 Global Opioid Tolerance Treatment Revenue Forecast by Type 2019-2025
- 12.3 Opioid Tolerance Treatment Market Forecast by Application
- 12.4 North America Opioid Tolerance Treatment Forecast
- 12.5 Europe Opioid Tolerance Treatment Forecast
- 12.6 Asia Pacific Opioid Tolerance Treatment Forecast
- 12.7 Central & South America Opioid Tolerance Treatment Forecast
- 12.8 Middle East and Africa Opioid Tolerance Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioid Tolerance Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioid Tolerance Treatment . Industry analysis & Market Report on Opioid Tolerance Treatment is a syndicated market report, published as Global Opioid Tolerance Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Opioid Tolerance Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
